Unique Aortic Aneurysm Repair Shows Promise: W.L. Gore Thoracic Single Side Branch Endograft

San Diego – January 29, 2015 — A novel, minimally invasive approach appears safe for treating life-threatening aneurysms that occur in the deepest part of the aorta, making it easier for surgeons to repair the aorta without opening the chest and easier for patients to recover. The approach was described at the 51st Annual Meeting of The Society of Thoracic Surgeons.

Analysis Rejects Linkage Between Testosterone Therapy, Cardiovascular Risk

January 27, 2015 — Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, according to a review published in this month's Mayo Clinic Proceedings. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration (FDA) panel convened last fall.

Spectranetics Completes Acquisition of Covidien’s Stellarex Drug-Coated Balloon

COLORADO SPRINGS, Colo., Jan. 27, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation announced it has completed the acquisition of Covidien's Stellarex drug-coated balloon angioplasty (DCB) platform. The transaction closed after the acquisition of Covidien by Medtronic.

The Stellarex DCB platform received European CE mark approval in December 2014. Spectranetics launched the product in Europe today, with U.S. commercialization anticipated in the 2017 timeframe, following FDA approval.

ISET: Clinical Work and Data Will be Presented on Humacyte’s Novel Bioengineered Blood Vessel

RESEARCH TRIANGLE PARK, N.C. – January 26, 2015 -- Jeffrey H. Lawson, M.D., Ph.D., Vice Chair for Research, Professor of Surgery and Pathology at Duke University Medical Center (Durham, N.C.), Director of the Vascular Research Laboratory, Director of Clinical Trials for the Department of Surgery and clinical consultant to Humacyte, a pioneering biotechnology firm, is the keynote speaker at the 27th International Symposium on Endovascular Therapy. ISET, held Jan. 31 to Feb.

Medtronic Study Finds CoreValve Benefits Aortic Stenosis Patients with Prior CABG

Analysis is First to Show Significant Advantages for Transcatheter Aortic Valve in Patients with Prior Coronary Artery Bypass Graft Surgery

Biosensors Enters Into Distribution Agreement with Veryan for BioMimics 3D Stent

28 January 2015 – Biosensors International Group has announced a distribution agreement with Veryan Medical Ltd. for BioMimics 3D™, a nitinol stent with unique three-dimensional helical geometry designed for use in the superficial femoral artery.  The agreement covers certain international markets, but excludes the USA and Japan.


Abiomed Receives FDA HDE Approval for the Impella RP

First FDA Approved Percutaneous Single Access Heart Pump Designed for Right Heart Support

Cardiologist Dr. Robert Califf named FDA Deputy Commissioner for Medical Products and Tobacco

January 26, 2015 — U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D., today appointed Robert Califf, M.D., a recognized global leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Medical Products and Tobacco.  

AIM RADIAL 2014 3rd Advanced International Masterclass

Transradial Approach in the World

New Zealand

Interventional Cardiology and the Transradial Approach in New Zealand

Jim Stewart, Peter Barr, David Smyth, Andrew Kerr, Charmaine Flynn.

Green Lane Cardiovascular Service, Auckland City Hospital, New Zealand

Back to top